Literature DB >> 8394860

Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis.

L F Xi1, W Demers, N B Kiviat, J Kuypers, A M Beckmann, D A Galloway.   

Abstract

Human papillomavirus (HPV) type 16 variants were found by single-strand conformation polymorphism (SSCP) analysis of the noncoding region of the viral genome. Two sets of primers were used to analyze a 1018 bp region spanning nucleotides 7109-222. Twelve SSCP patterns were demonstrated among HPV 16 DNAs purified from 48 anal specimens from 24 homosexual men. Seven patterns were detected among 10 HPV 16 isolates from cervical carcinomas. In two pairs of sex partners, identical variants were recognized in each partner of the pair. Infection with two variants of HPV 16 from 2 specimens was observed in 1 of 21 subjects for whom there were multiple samples over time. DNA sequence analysis of 7 isolates confirmed that the SSCP technique showed polymorphisms only in fragments that had base substitutions and that all of these base substitutions resulted in detectable shifts in fragment mobility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394860     DOI: 10.1093/infdis/168.3.610

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Applications of polymerase chain reaction-single stranded conformational polymorphism to microbiology.

Authors:  J R Kerr; M D Curran
Journal:  Clin Mol Pathol       Date:  1996-12

2.  Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies.

Authors:  R Tachezy; I Mikysková; V Ludvíková; L Rob; T Kucera; V Slavík; A Beková; H Robová; M Pluta; E Hamsíková
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

3.  Intratype variation in 12 human papillomavirus types: a worldwide perspective.

Authors:  A C Stewart; A M Eriksson; M M Manos; N Muñoz; F X Bosch; J Peto; C M Wheeler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 4.  Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

5.  Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.

Authors:  M H Mayrand; F Coutlée; C Hankins; N Lapointe; P Forest; M de Ladurantaye; M Roger
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Comparison of variant-specific hybridization and single-strand conformational polymorphism methods for detection of mixed human papillomavirus type 16 variant infections.

Authors:  R T Emeny; J R Herron; L F Xi; L A Koutsky; N B Kiviat; C M Wheeler
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

7.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Evaluation of non-radioactive temperature gradient SSCP analysis and of temperature gradient gel electrophoresis for the detection of HPV 6-variants in condylomata acuminata and Buschke-Loewenstein tumours.

Authors:  A Rübben; C Traidl; J M Baron; E I Grussendorf-Conen
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

9.  Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients.

Authors:  A van Belkum; L Juffermans; L Schrauwen; G van Doornum; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

10.  Detailed Characteristics of Tonsillar Tumors with Extrachromosomal or Integrated Form of Human Papillomavirus.

Authors:  Barbora Pokrývková; Martina Saláková; Jana Šmahelová; Zuzana Vojtěchová; Vendula Novosadová; Ruth Tachezy
Journal:  Viruses       Date:  2019-12-30       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.